| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA1203458
Max Phase: Preclinical
Molecular Formula: C12H14ClFN4O
Molecular Weight: 248.26
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Cl.O=C(NCCCn1cncn1)c1ccccc1F
Standard InChI: InChI=1S/C12H13FN4O.ClH/c13-11-5-2-1-4-10(11)12(18)15-6-3-7-17-9-14-8-16-17;/h1-2,4-5,8-9H,3,6-7H2,(H,15,18);1H
Standard InChI Key: LZLDSHPZVLMAIC-UHFFFAOYSA-N
Associated Targets(non-human)
Thromboxane-A synthase 658 Activities
Rattus norvegicus 775804 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 248.26 | Molecular Weight (Monoisotopic): 248.1073 | AlogP: 1.24 | #Rotatable Bonds: 5 |
| Polar Surface Area: 59.81 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 13.27 | CX Basic pKa: 2.29 | CX LogP: 0.79 | CX LogD: 0.79 |
| Aromatic Rings: 2 | Heavy Atoms: 18 | QED Weighted: 0.81 | Np Likeness Score: -2.62 |
References
| 1. Wright WB, Press JB, Chan PS, Marsico JW, Haug MF, Lucas J, Tauber J, Tomcufcik AS.. (1986) Thromboxane synthetase inhibitors and antihypertensive agents. 1. N-[(1H-imidazol-1-yl)alkyl]aryl amides and N-[(1H-1,2,4-triazol-1-yl)alkyl]aryl amides., 29 (4): [PMID:3959030] [10.1021/jm00154a017] |
Source
Source(1):